Anti-angiogenesis drugs: These drugs, which include angiostatin and Endostatin, halt the process of developing new blood vessels (angiogenesis). Angiostatin is a piece of a larger and very common protein, plasminogen, that the body uses in blood clotting. Endostatin is a piece of a different protein, collagen 18, that is in all blood vessels. Both angiostatin and Endostatin are normally secreted by tumors. It is hoped that they will provide the basis for a new class of agents to treat cancer.
The U.S. Food and Drug Administration (FDA) has approved bevacizumab (Avastin ®) for use with other drugs to treat colorectal cancer that has spread to other parts of the ...
Treatments and Side Effects Treatment Types Anti-angiogenesis Treatment ... Cancer.org is provided courtesy of Leo and Gloria Rosen family. © 2011 ...
Anti-angiogenesis drugs don't attack cancer cells directly.
Currently hundreds of anti-angiogenesis drugs being studied. ... Although progress has been made in the early detection of cancer, and in improved treatment options once ...
Anti-angiogenesis drugs: These drugs, which include angiostatin and Endostatin, halt the process of developing new blood vessels (angiogenesis).